HOWARD W. ROBIN

Insider Reports History

Location
San Francisco, CA
Signature
Mark A. Wilson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by HOWARD W. ROBIN:

Company Role Class Num Shares Value Price $ Report Date Ownership
NEKTAR THERAPEUTICS President & CEO, Director Common Stock 75,912 $4,120,503 $54.28 22 Dec 2025 Direct
NEKTAR THERAPEUTICS President & CEO, Director Common Stock 28 $1,519 $54.28 22 Dec 2025 by spouse
NEKTAR THERAPEUTICS President & CEO, Director Stock Option 86,667 22 Dec 2025 Direct

Insider Reports Filed by HOWARD W. ROBIN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NKTR NEKTAR THERAPEUTICS 22 Dec 2025 2 $0 4 President & CEO, Director 23 Dec 2025, 18:01
NKTR NEKTAR THERAPEUTICS 21 Nov 2025 3 -$119,796 4 President & CEO, Director 25 Nov 2025, 20:28
NKTR NEKTAR THERAPEUTICS 09 Sep 2025 4 -$311,214 4 President & CEO, Director 11 Sep 2025, 21:01
NKTR NEKTAR THERAPEUTICS 04 Sep 2025 7 -$430,959 4 President & CEO, Director 08 Sep 2025, 20:31
NKTR NEKTAR THERAPEUTICS 02 Sep 2025 1 -$45,240 4 President & CEO, Director 04 Sep 2025, 21:01
NKTR NEKTAR THERAPEUTICS 19 Aug 2025 2 -$41,826 4 President & CEO, Director 21 Aug 2025, 21:03
NKTR NEKTAR THERAPEUTICS 19 May 2025 1 -$15,549 4 President & CEO, Director 21 May 2025, 20:07
NKTR NEKTAR THERAPEUTICS 19 Feb 2025 1 -$24,012 4 President & CEO, Director 21 Feb 2025, 18:04
NKTR NEKTAR THERAPEUTICS 17 Dec 2024 2 -$131,650 4 President & CEO, Director 19 Dec 2024, 21:08
NKTR NEKTAR THERAPEUTICS 13 Dec 2024 3 $0 4 President & CEO, Director 17 Dec 2024, 20:54
NKTR NEKTAR THERAPEUTICS 19 Nov 2024 1 -$16,441 4 President & CEO, Director 20 Nov 2024, 20:36
NKTR NEKTAR THERAPEUTICS 19 Aug 2024 1 -$19,048 4 President & CEO, Director 20 Aug 2024, 21:14
NKTR NEKTAR THERAPEUTICS 17 May 2024 1 -$29,138 4 President & CEO, Director 20 May 2024, 21:14
NKTR NEKTAR THERAPEUTICS 20 Feb 2024 1 -$13,622 4 President & CEO, Director 22 Feb 2024, 20:16
NKTR NEKTAR THERAPEUTICS 13 Dec 2023 1 $0 4 President & CEO, Director 15 Dec 2023, 18:05
NKTR NEKTAR THERAPEUTICS 17 Nov 2023 1 -$9,740 4 President & CEO, Director 20 Nov 2023, 20:58
NKTR NEKTAR THERAPEUTICS 16 Aug 2023 1 -$15,598 4 President & CEO, Director 17 Aug 2023, 21:06
NKTR NEKTAR THERAPEUTICS 16 May 2023 1 -$14,660 4 President & CEO, Director 17 May 2023, 20:27
NKTR NEKTAR THERAPEUTICS 16 Feb 2023 1 -$58,905 4 President & CEO, Director 17 Feb 2023, 19:57
NKTR NEKTAR THERAPEUTICS 16 Nov 2022 1 -$135,710 4 President & CEO, Director 18 Nov 2022, 17:02
NKTR NEKTAR THERAPEUTICS 15 Aug 2022 3 -$65,493 4 President & CEO, Director 17 Aug 2022, 19:39
NKTR NEKTAR THERAPEUTICS 15 May 2022 2 -$144,290 4 President & CEO, Director 17 May 2022, 21:35
NKTR NEKTAR THERAPEUTICS 16 Feb 2022 1 -$136,656 4 President & CEO, Director 18 Feb 2022, 17:16
NKTR NEKTAR THERAPEUTICS 16 Dec 2021 2 $0 4 President & CEO, Director 20 Dec 2021, 19:25
NKTR NEKTAR THERAPEUTICS 15 Nov 2021 2 -$562,893 4 President & CEO, Director 17 Nov 2021, 17:07
NKTR NEKTAR THERAPEUTICS 12 Oct 2021 1 $0 4 President & CEO, Director 14 Oct 2021, 21:06
NKTR NEKTAR THERAPEUTICS 16 Aug 2021 1 -$159,252 4 President & CEO, Director 18 Aug 2021, 19:01
NKTR NEKTAR THERAPEUTICS 17 May 2021 1 -$211,548 4 President & CEO, Director 19 May 2021, 19:05